 |
 |
|
|
     |
Exciting News from NorthStar Nuclear Medicine!
Rapid market expansion is occurring in diagnostic radioisotope enhanced imaging procedures (CatScan, MRI, X-Ray and ultrasound) and more importantly radioisotopes are being employed as a therapy for cancer, leukemia, heart disease, Parkinson’s Disease and other diseases. There is a fundamental belief that herein lies the cure for deadly and debilitating diseases being treated with molecules which can seek and attach radioisotopes to tumors and cancerous growths. This overall market is estimated to be a $10 billion market that is expected to realize an annual growth rate in excess of 10% per year for the next five (5) years.
Our MissionNorthStar’s ability to provide solutions in the areas where no solution exists, establishing sourcing of hard to get radioisotopes and a distribution channel of owned nuclear pharmacies will brand NorthStar as: “Enabling the future of nuclear medicine”
Company ProfileNorthStar Nuclear Medicine, LLC, (“NorthStar” or the “Company”) was founded in 2004 by the principals of NorthStar Growth Partners, LLC (“NGP”) located in Janesville, WI. NGP has obtained exclusive access to worldwide patents through a License Agreement obtained from PG Research Foundation1 . The patented technologies (equipment, methods and procedures – collectively the “Technology”) have many separable market applications and broadly contain methods and instrumentation which solve a myriad of problems in producing ultrapure radioisotopes. One such market is for nuclear medicine and NGP has given the Company an exclusive worldwide right to exploit the technology in this marketplace. The Company’s management has recognized that these technologies can be successfully deployed into the explosive, emerging, and ever-changing nuclear medicine market and will have the ability to revolutionize the methods and processes used in the production and distribution of radioisotopes, particularly short-lived ones, and ultimately their associated radiopharmaceuticals. The Company will create instrumentation and associated disposables for radionuclide separation, dosing, and dispensing, all for sale to research laboratories and its Company portfolio of existing nuclear pharmacies throughout United States, will provide sources for hard to get radioisotopes. This Company will enable researchers to expand diagnostic and therapy choices of desired isotopes to conduct research upon, and mitigate a significant portion of the risk associated with the production and conjugation (linking together), and administration of the radiopharmaceutical. NorthStar’s technology will be incorporated and utilized by these research laboratories and also nuclear pharmacies NorthStar acquires. Besides making new isotopes available in sufficient quantity for research, NorthStar will set new standards for safety, purity and dose consistency. 1 PGRF is the PG Research Foundation Inc., a GCI Company, located at 8205 South Cass Avenue, Suite 106 ● Darien Illinois. It is a technology development company with a high level of expertise in chemical separation knowledge and significant experience in separating nuclear Isotopes. Its founder, E. Phil Horwitz is a retired Senior Scientist of Argonne National Laboratory in Argonne, IL and has a distinguished career in this area of science.
Contact InformationWe are continuing to update our website and appreciate your patience during this period. If you have questions and would like more information please feel free to contact General Information listed below and we will assist you. We are soliciting any interest in radioisotopes that would meet the needs of today's researchers. By using the hyperlink below then Faxing or emailing a completed form to our attention, our staff will review and contact the sender to obtain further information. Radioisotope Expression of Need Form. PDF++ Radioisotope Expression of Interest Form.doc++ ++All of your information will be considered confidential and will be used by the Company for the sole purpose of evaluating the collective needs of the industry.
|
|
Send mail to
webmaster@northstarnm.com with
questions or comments about this web site.
|
NorthStar
Nuclear Medicine, LLC is an early stage company destined to take advantage of
the challenging, ever changing and dynamic nuclear medicine market. NorthStar
Nuclear Medicine is strategically equipped to become a key player in this market with products
and services for diagnostic
and therapeutic radioisotopes.